PTK2 and hepatocellular carcinoma: Importantly, overexpression of Lrp4 and MuSK in HCC tumours (8 out of 11 HCC patients; Supplementary Fig. 14d) is consistent with the notion that Agrin functions through the Lrp4–MuSK complex to activate FAK in driving the oncogenic programme of HCC cells.